Digital Pathology Market Report Forecasts Strong Growth by 2022 - Scalar Market Research
What Are The Key Industry Insights Of Digital Pathology Market? Know The Key Players with Forecasts by 2022?
Chicago, IL -- (SBWire) -- 05/31/2017 --According to the new market research report, "Digital Pathology Market, by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Tele-consultation, Drug Discovery) – Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022", published by Scalar Market Research, the global Digital Pathology Market is expected to grow at a healthy rate during the forecast period of the next four to five years.
Download Free sample: https://www.scalarmarketresearch.com/request-sample.php?id=911
The global Digital Pathology Market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Enquiry Before Buying: https://www.scalarmarketresearch.com/enquire-before-buy.php?id=911
KEY PREMIUM INDUSTRY INSIGHTS
1. The digital pathology market is predicted to be one of the fastest growing markets across the globe. The successive implementation of IT in healthcare sectors is the dynamic factor for digital pathology industry.
2. The demand for digital pathology equipment is growing across the globe owing to rise in multi-specialty hospitals and set-up of isolated pathology laboratories equipped with high end technology.
3. Further, rise in aging population and growing prevalence of cardiac and cardiovascular diseases among the population further increases the diagnosis demand in order to take preventive measures.
4. Technological advancements in pathology sector and digitalization of pathology will shift the conventional pathology to a cutting-edge level of diagnosis.
Regionally, North America is expected to remain the dominant market in the global digital pathology market throughout the forecast period. The U.S. market is expected to remain the dominant market among other countries in North America throughout the forecast period owing to supporting government policies encouraging adoption of healthcare IT services. Western Europe market is followed by the North America market as more number of players are expected to enter into the former market during the forecast period. Japan is expected to be the next lucrative market for digital pathology companies.
Browse Report: https://www.scalarmarketresearch.com/market-reports/digital-pathology-market
KEY MARKET PLAYERS
Key players in the digital pathology market include:
1.Hamamatsu Photonics K.K.
2.3dhistech Ltd.
3.Philips Healthcare
4.Apollo Enterprise Imaging Corp. (Formerly Apollo Pacs, Inc.)
5.Xifin, Inc.
6.Definiens AG
7.Visiopharm A/S
8.Omnyx, LLC (Venture By Ge Healthcare and UPMC)
9.Corista LLC
About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.
Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degreeperspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of the global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.
Find out more about our services at: www.scalarmarketresearch.com
Media Relations Contact
George Molakal
CEO
Scalar Market Research
1-800-213-5170
https://www.scalarmarketresearch.com/market-reports/digital-pathology-market
View this press release online at: http://rwire.com/813751